Fibroblast Growth Factor Receptor 3 Alteration Status is Associated with Differential Sensitivity to Platinum-based Chemotherapy in Locally Advanced and Metastatic Urothelial Carcinoma
Min Yuen Teo, José Maurício Mota, Karissa Whiting, Han A. Li, Samuel A. Funt, Chung‐Han Lee, David B. Solit, Hikmat Al‐Ahmadie, Matthew I. Milowsky, Arjun Vasant Balar, Eugene J. Pietzak, Guido Dalbagni, Bernard H. Bochner, Irina Ostrovnaya, Dean F. Bajorin, Jonathan E. Rosenberg, Gopa Iyer
Topics & Concepts
MedicineMetastatic Urothelial CarcinomaChemotherapyFibroblast growth factor receptorUrothelial carcinomaFibroblast growth factor 23Cancer researchOncologyFibroblast growth factor receptor 3Internal medicineCarcinomaReceptorFibroblast growth factorUrologyCancerBladder cancerCalciumParathyroid hormoneBladder and Urothelial Cancer TreatmentsFibroblast Growth Factor ResearchRenal cell carcinoma treatment